These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19633522)

  • 1. Aplastic anemia following varicella vaccine.
    Angelini P; Kavadas F; Sharma N; Richardson SE; Tipples G; Roifman C; Dror Y; Nofech-Mozes Y
    Pediatr Infect Dis J; 2009 Aug; 28(8):746-8. PubMed ID: 19633522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
    Armenian SH; Han JY; Dunaway TM; Church JA
    Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large injection site reactions after a second dose of varicella vaccine.
    Walter EB; Snyder MA; Clements DA; Katz SL
    Pediatr Infect Dis J; 2008 Aug; 27(8):757-9. PubMed ID: 18574438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis and characteristics of breakthrough varicella in children.
    Weinmann S; Chun C; Mullooly JP; Riedlinger K; Houston H; Loparev VN; Schmid DS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S132-8. PubMed ID: 18419386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of varicella vaccine.
    Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
    Quinlivan M; Gershon AA; Steinberg SP; Breuer J
    J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incorporation of varicella-zoster virus vaccination in childhood immunization schedules].
    Rothbart H; Rishpon S
    Harefuah; 2008; 147(8-9):693-7, 751, 750. PubMed ID: 18935757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection.
    van der Maas NA; Bondt PE; de Melker H; Kemmeren JM
    Vaccine; 2009 Mar; 27(13):1970-3. PubMed ID: 19186201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
    Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
    J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
    Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
    Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for genetics in the immune response to the varicella vaccine.
    Klein NP; Fireman B; Enright A; Ray P; Black S; Dekker CL;
    Pediatr Infect Dis J; 2007 Apr; 26(4):300-5. PubMed ID: 17414391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction.
    Jean-Philippe P; Freedman A; Chang MW; Steinberg SP; Gershon AA; LaRussa PS; Borkowsky W
    Pediatrics; 2007 Nov; 120(5):e1345-9. PubMed ID: 17974726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.